Pages that link to "Q35221988"

The following pages link to Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells (Q35221988):

Displaying 41 items.

• Androgen receptor variants occur frequently in castration resistant prostate cancer metastases (Q21558502) (← links)
• Androgen receptor molecular biology and potential targets in prostate cancer (Q24602861) (← links)
• Androgen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinases (Q26866135) (← links)
• Transcriptional activity of c-Jun is critical for the suppression of AR function (Q30412500) (← links)
• Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells (Q30500293) (← links)
• Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer (Q33968384) (← links)
• Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors (Q33989603) (← links)
• Short hairpin RNA library-based functional screening identified ribosomal protein L31 that modulates prostate cancer cell growth via p53 pathway (Q34294283) (← links)
• Role of androgen receptor in progression of LNCaP prostate cancer cells from G1 to S phase (Q34599285) (← links)
• Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells (Q35109795) (← links)
• Mechanisms mediating androgen receptor reactivation after castration (Q35633454) (← links)
• Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 Activation. (Q35694048) (← links)
• MicroRNA Library-Based Functional Screening Identified Androgen-Sensitive miR-216a as a Player in Bicalutamide Resistance in Prostate Cancer (Q35823109) (← links)
• Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation. (Q35868187) (← links)
• Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer (Q36777961) (← links)
• Targeting the androgen receptor pathway in prostate cancer (Q36953028) (← links)
• Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development (Q36959438) (← links)
• Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis (Q36961208) (← links)
• Posttranslational modification of the androgen receptor in prostate cancer (Q37092022) (← links)
• AR, the cell cycle, and prostate cancer (Q37095260) (← links)
• Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer. (Q37098796) (← links)
• Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins (Q37112738) (← links)
• RNA editing of androgen receptor gene transcripts in prostate cancer cells (Q37142544) (← links)
• Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP. (Q37161795) (← links)
• Src controls castration recurrence of CWR22 prostate cancer xenografts (Q37481145) (← links)
• Novel, potent anti-androgens of therapeutic potential: recent advances and promising developments. (Q37855836) (← links)
• Androgen action and metabolism in prostate cancer (Q37997571) (← links)
• Evolution of androgen receptor targeted therapy for advanced prostate cancer (Q38212716) (← links)
• Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals (Q39174448) (← links)
• Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling (Q39665818) (← links)
• Down-regulation of androgen-receptor and PSA by phytochemicals (Q40023730) (← links)
• Mithramycin targets sp1 and the androgen receptor transcription level-potential therapeutic role in advanced prostate cancer (Q40317888) (← links)
• Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer (Q41592660) (← links)
• TREMOR--a tool for retrieving transcriptional modules by incorporating motif covariance. (Q41835652) (← links)
• Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase (Q41839868) (← links)
• 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action (Q42277586) (← links)
• Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cells (Q42758453) (← links)
• Reliability of a composite measure of social inclusion for people with psychiatric disabilities (Q51893327) (← links)
• Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer (Q89115406) (← links)
• Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway (Q90134570) (← links)
• The Role of RB in Prostate Cancer Progression (Q92410942) (← links)